SCHEMBL4191285

SCHEMBL4191285

CC(C)CSC(O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHCY P23526 5/20 0.59
NADK O95544 1/20 0.59
DOT1L Q8TEK3 2/20 0.58
ADORA3 P0DMS8 3/20 0.58
ADORA2A P29274 2/20 0.58
ADORA2B P29275 2/20 0.58
ADORA1 P30542 2/20 0.58
KMT2A Q03164 2/20 0.58
DPP4 P27487 1/20 0.58
MEN1 O00255 1/20 0.58
SLC28A1 O00337 1/20 0.58
MAP3K7 O43318 1/20 0.58
SLC28A2 O43868 1/20 0.58
GAPDH P04406 1/20 0.58
MAPK1 P28482 1/20 0.58
STAT6 P42226 1/20 0.58
PI4KA P42356 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
PI4K2B Q8TCG2 1/20 0.58
SLC29A1 Q99808 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118345 0.89 AHCY (0.61) AHCYNADKDOT1LADORA3ADORA2A
SCHEMBL6894498 0.87 AHCY (0.59) AHCYNADKDOT1LADORA3ADORA2A
SCHEMBL101380 0.87 AHCY (0.62) AHCYNADKDOT1LADORA3ADORA2A
SCHEMBL13173634 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL22326787 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL16300875 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL22326785 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL21413837 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL18520788 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B
SCHEMBL800346 0.86 PRMT5 (0.64) AHCYDOT1LADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357881-A4 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION QUARK PHARMACEUTICALS INC (US) 2009-02-18 EP claimed
US-20040229886-A1 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation QUARK BIOTECH, INC. & SHIONOGI CO., LTD. 2004-11-18 US claimed
US-6696454-B2 ADMINISTERING AN INHIBITOR OF SPERMIDINE BIOSYNTHESIS; PREFERRED ARE DCHA (DICYCLOHEXYLAMINE), ADODATO, AND TRANS-4-METHYLCYCLOHEXYLAMINE (4MCHA) QUARK BIOTECH, INC. 2004-02-24 US claimed
EP-1357881-A2 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION Quark Biotech, Inc. (US) 2003-11-05 EP claimed
US-20020160978-A1 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation QUARK PHARMACEUTICALS, INC. 2002-10-31 US claimed
WO-2002058623-A2 INHIBITORS OF SPERMIDINE SYNTHASE FOR THE TREATMENT OF OSTEOARTHRITIS AND CARTILAGE REHABILITATION QUARK BIOTECH, INC. (US) 2002-08-01 WO claimed
US-6696454-B2 ADMINISTERING AN INHIBITOR OF SPERMIDINE BIOSYNTHESIS; PREFERRED ARE DCHA (DICYCLOHEXYLAMINE), ADODATO, AND TRANS-4-METHYLCYCLOHEXYLAMINE (4MCHA) QUARK BIOTECH, INC. 2004-02-24 US disclosed
US-20020160978-A1 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation QUARK PHARMACEUTICALS, INC. 2002-10-31 US disclosed